Health economic implications of irbesartan plus conventional antihypertensive medications versus conventional blood pressure control alone in patierns with type 2 diabetes, hypertension, and renal disease in Switzerland. (2006). Swiss Medical Weekly, 136(2122), 346-346. https://doi.org/10.57187/smw.2006.11337